Biocon informs about investor release

30 Dec 2024 Evaluate

Biocon has informed that it enclosed a notification titled ‘Biocon Biologics has fulfilled its obligations towards all deferred milestones under the acquisition agreement with Viatris. This also marks, as full and final remittance of considerations from Biocon Biologics toward Viatris for the acquisition.] The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

324.90 8.35 (2.64%)
15-Apr-2025 09:32 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.20
Dr. Reddys Lab 1144.15
Cipla 1482.55
Lupin 2005.40
Zydus Lifesciences 878.80
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...